During the corresponding time, Clever Leaves Holdings Inc recorded a revenue increase by 6.42 % year on year, sequentially revenue grew by 66.89 %. While revenue at the Clever Leaves Holdings Inc 's corporate clients
Clever Leaves Holdings Inc's Comment on Sales, Marketing and Customers
The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Its medical cannabinoid business operates large-scale cultivation and processing facilities in Colombia, including approximately 1.8 million square feet of greenhouse cultivation capacity and a pharmaceutical-grade extraction facility. The Colombian operations hold EU GMP certification. The company ceased operations in Portugal as of January 2024. Through its subsidiary Herbal Brands, Inc., it markets and distributes nutraceutical and wellness products to more than 20,000 retail locations across the United States. The principal operations are in Colombia, where the company maintains 18 greenhouses and holds GACP and IMC-GAP GACP certifications to produce pharmaceutical-grade cannabis products for domestic and international markets.
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), the global leader in medicinal cannabis, has embarked on a groundbreaking partnership with renowned Dutch seed bank, Paradise Seeds, to develop and register exceptional genetic assets in Colombia. This collaboration aims to revolutionize the cultivation and commercialization of high-performance cannabis cultivars in Colombia and Latin America.As part of this exclusive alliance, Clever Leaves will obtain a license to cultivate select genetics, while Paradise Seeds will offer other cultivars to third parties for cultivation across the region. Recognizing the immense potential that lies within cannabis genetics, these two industry giants have wasted no time in...
Clever Leaves Holdings Inc’s Comment on Sales, Marketing and Customers
The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Its medical cannabinoid business operates large-scale cultivation and processing facilities in Colombia, including approximately 1.8 million square feet of greenhouse cultivation capacity and a pharmaceutical-grade extraction facility. The Colombian operations hold EU GMP certification. The company ceased operations in Portugal as of January 2024. Through its subsidiary Herbal Brands, Inc., it markets and distributes nutraceutical and wellness products to more than 20,000 retail locations across the United States. The principal operations are in Colombia, where the company maintains 18 greenhouses and holds GACP and IMC-GAP GACP certifications to produce pharmaceutical-grade cannabis products for domestic and international markets.
Sources:
Clever Leaves Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Clever Leaves Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Clever Leaves Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
